Connection
Rohit Dhall to Selegiline
This is a "connection" page, showing publications Rohit Dhall has written about Selegiline.
|
|
Connection Strength |
|
|
|
|
|
0.129 |
|
|
|
-
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 2015 Aug; 14(8):795-803.
Score: 0.129